Search research articles
Contact Us
Filters
Showing results (61-70 of 78) with videos related to
Page
of 8
Sort By:
Oncology Reports
|
May 21, 2014
YKL-40 downregulation is a key factor to overcome temozolomide resistance in a glioblastoma cell line
Yasuto Akiyama, Tadashi Ashizawa, Masaru Komiyama, et al.
International Journal of Clinical Oncology
|
August 18, 2011
Leptomeningeal carcinomatosis associated with gastric cancer
Hideharu Tomita, Hirofumi Yasui, Narikazu Boku, et al.
Cancer Genomics & Proteomics
|
December 30, 2016
Combination of a STAT3 Inhibitor and an mTOR Inhibitor Against a Temozolomide-resistant Glioblastoma Cell Line
Haruo Miyata, Tadashi Ashizawa, Akira Iizuka, et al.
BMC Cancer
|
December 29, 2012
α-type-1 polarized dendritic cell-based vaccination in recurrent high-grade glioma: a phase I clinical trial
Yasuto Akiyama, Chie Oshita, Akiko Kume, et al.
BMC Cancer
|
June 4, 2017
A nationwide multi-institutional retrospective study to identify prognostic factors and develop a graded prognostic assessment system for patients with brain metastases from uterine corpus and cervical cancer
Nakamasa Hayashi, Hideaki Takahashi, Yuzo Hasegawa, et al.
Immunology Letters
|
July 19, 2017
The anti-tumor activity of the STAT3 inhibitor STX-0119 occurs via promotion of tumor-infiltrating lymphocyte accumulation in temozolomide-resistant glioblastoma cell line
Yasuto Akiyama, Chizu Nonomura, Tadashi Ashizawa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 27, 2016
Antitumor Effect of Programmed Death-1 (PD-1) Blockade in Humanized the NOG-MHC Double Knockout Mouse
Tadashi Ashizawa, Akira Iizuka, Chizu Nonomura, et al.
Lung Cancer (Amsterdam, Netherlands)
|
May 17, 2011
Continuous EGFR-TKI administration following radiotherapy for non-small cell lung cancer patients with isolated CNS failure
Takehito Shukuya, Toshiaki Takahashi, Tateaki Naito, et al.
Plos One
|
August 11, 2011
The global DNA methylation surrogate LINE-1 methylation is correlated with MGMT promoter methylation and is a better prognostic factor for glioma
Fumiharu Ohka, Atsushi Natsume, Kazuya Motomura, et al.
Oncology Reports
|
February 28, 2014
Novel cancer-testis antigen expression on glioma cell lines derived from high-grade glioma patients
Yasuto Akiyama, Masaru Komiyama, Haruo Miyata, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 78) with videos related to
Sort By:
Page
of 8
Oncology Reports
|
May 21, 2014
YKL-40 downregulation is a key factor to overcome temozolomide resistance in a glioblastoma cell line
Yasuto Akiyama, Tadashi Ashizawa, Masaru Komiyama, et al.
International Journal of Clinical Oncology
|
August 18, 2011
Leptomeningeal carcinomatosis associated with gastric cancer
Hideharu Tomita, Hirofumi Yasui, Narikazu Boku, et al.
Cancer Genomics & Proteomics
|
December 30, 2016
Combination of a STAT3 Inhibitor and an mTOR Inhibitor Against a Temozolomide-resistant Glioblastoma Cell Line
Haruo Miyata, Tadashi Ashizawa, Akira Iizuka, et al.
BMC Cancer
|
December 29, 2012
α-type-1 polarized dendritic cell-based vaccination in recurrent high-grade glioma: a phase I clinical trial
Yasuto Akiyama, Chie Oshita, Akiko Kume, et al.
BMC Cancer
|
June 4, 2017
A nationwide multi-institutional retrospective study to identify prognostic factors and develop a graded prognostic assessment system for patients with brain metastases from uterine corpus and cervical cancer
Nakamasa Hayashi, Hideaki Takahashi, Yuzo Hasegawa, et al.
Immunology Letters
|
July 19, 2017
The anti-tumor activity of the STAT3 inhibitor STX-0119 occurs via promotion of tumor-infiltrating lymphocyte accumulation in temozolomide-resistant glioblastoma cell line
Yasuto Akiyama, Chizu Nonomura, Tadashi Ashizawa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 27, 2016
Antitumor Effect of Programmed Death-1 (PD-1) Blockade in Humanized the NOG-MHC Double Knockout Mouse
Tadashi Ashizawa, Akira Iizuka, Chizu Nonomura, et al.
Lung Cancer (Amsterdam, Netherlands)
|
May 17, 2011
Continuous EGFR-TKI administration following radiotherapy for non-small cell lung cancer patients with isolated CNS failure
Takehito Shukuya, Toshiaki Takahashi, Tateaki Naito, et al.
Plos One
|
August 11, 2011
The global DNA methylation surrogate LINE-1 methylation is correlated with MGMT promoter methylation and is a better prognostic factor for glioma
Fumiharu Ohka, Atsushi Natsume, Kazuya Motomura, et al.
Oncology Reports
|
February 28, 2014
Novel cancer-testis antigen expression on glioma cell lines derived from high-grade glioma patients
Yasuto Akiyama, Masaru Komiyama, Haruo Miyata, et al.
Page
of 8